OPKO Health Inc (OPK)
1.46
-0.02
(-1.35%)
USD |
NASDAQ |
Nov 05, 16:00
1.46
0.00 (0.00%)
After-Hours: 16:14
OPKO Health Revenue (Quarterly): 182.19M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 182.19M |
| March 31, 2024 | 173.69M |
| December 31, 2023 | 181.90M |
| September 30, 2023 | 178.60M |
| June 30, 2023 | 265.42M |
| March 31, 2023 | 237.58M |
| December 31, 2022 | 185.34M |
| September 30, 2022 | 179.74M |
| June 30, 2022 | 309.89M |
| March 31, 2022 | 329.22M |
| December 31, 2021 | 401.33M |
| September 30, 2021 | 385.81M |
| June 30, 2021 | 442.41M |
| March 31, 2021 | 545.16M |
| December 31, 2020 | 494.67M |
| September 30, 2020 | 428.06M |
| June 30, 2020 | 301.21M |
| March 31, 2020 | 211.47M |
| December 31, 2019 | 224.34M |
| September 30, 2019 | 228.77M |
| June 30, 2019 | 226.37M |
| March 31, 2019 | 222.45M |
| December 31, 2018 | 221.85M |
| September 30, 2018 | 249.82M |
| June 30, 2018 | 263.68M |
| Date | Value |
|---|---|
| March 31, 2018 | 254.91M |
| December 31, 2017 | 160.98M |
| September 30, 2017 | 246.04M |
| June 30, 2017 | 292.60M |
| March 31, 2017 | 266.38M |
| December 31, 2016 | 171.32M |
| September 30, 2016 | 298.04M |
| June 30, 2016 | 357.10M |
| March 31, 2016 | 291.04M |
| December 31, 2015 | 276.19M |
| September 30, 2015 | 143.03M |
| June 30, 2015 | 42.43M |
| March 31, 2015 | 30.08M |
| December 31, 2014 | 25.53M |
| September 30, 2014 | 19.77M |
| June 30, 2014 | 23.54M |
| March 31, 2014 | 22.27M |
| December 31, 2013 | 20.69M |
| September 30, 2013 | 20.64M |
| June 30, 2013 | 23.82M |
| March 31, 2013 | 31.38M |
| December 31, 2012 | 16.26M |
| September 30, 2012 | 11.80M |
| June 30, 2012 | 10.21M |
| March 31, 2012 | 8.777M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
173.69M
Minimum
Mar 2024
545.16M
Maximum
Mar 2021
297.79M
Average
265.42M
Median
Jun 2023
Revenue (Quarterly) Benchmarks
| Innerscope Hearing Technologies Inc | 0.2508M |
| Abbott Laboratories | 10.64B |
| Boston Scientific Corp | 4.209B |
| ICU Medical Inc | 596.46M |
| Outset Medical Inc | 27.39M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.30M |
| Total Expenses (Quarterly) | 243.86M |
| EPS Diluted (Quarterly) | -0.01 |
| Enterprise Value | 1.185B |
| Gross Profit Margin (Quarterly) | 28.35% |
| Profit Margin (Quarterly) | -5.66% |
| Earnings Yield | -22.60% |
| Normalized Earnings Yield | -20.20 |